Veterans / Military
While Cures Within Reach is disease-agnostic and geography-agnostic, some funding partners have strategic interests in specific population groups. Therefore, in addition to our disease-specific and geographic repurposing communities, we have a Veterans and Military Repurposing Community that utilizes the speed and cost-effectiveness of testing already approved therapies in new indications to improve the quality and length of life of retired military veterans and active US military.
We launched this on Veterans Day 2020 with our Clinical Repurposing for Veterans Initiative (full press release here). Our efforts include finding and funding clinical repurposing projects that address unmet and high priority medical needs of veterans and active military, including depression, post-traumatic stress disorder (PTSD) and brain injuries.
In Nov 2023, we approved 2 more veterans-focused clinical trials for funding:
- Daily Rotigotine Patch to Enhance Behavioral Therapy for Cocaine Use Disorder Recovery in Veterans at Virginia Commonwealth University
- Improving Cognitive Function in Veterans with Atypical Parkinsonism with rTMS Brain Stimulation at Edward Hines Jr. VA Hospital and CARES
Read our news release from August 14, 2024 here, describing the 2 veterans clinical trials selected from our 2023 RFP!
Funding Opportunity RFPs for Veterans / Military:
- US Based Repurposing Clinical Trials to Address Health Equity 2024: INVITE ONLY accepting budgets of up to $75,000 for repurposing clinical trials to address health equity, including repurposing clinical trials that EITHER are 1) led by an underrepresented researcher OR 2) address health disparities among underrepresented patients OR 3) both 1) and 2). PROPOSAL DEADLINE CLOSED; SUBMISSIONS UNDER REVIEW
- Impacting Blood Cancers through Clinical Repurposing Trials: clinical trials impacting veterans are eligible! Accepting budgets of up to $75,000 from institutions worldwide for clinical repurposing trials targeting any blood cancer, with a preference for trials impacting multiple myeloma and/or myelodysplastic syndromes. LOI DEADLINE CLOSED; SUBMISSIONS UNDER REVIEW
- Repurposing Research for Chicago 2024: accepting budgets of up to $100,000 for clinical repurposing trials from Chicago area research institutions. Veterans/Military is one of four Chicago RFP tracks. Specific focus areas for the other tracks include Diversity, Equity and Inclusion, Early Stage Investigators and Pediatrics. LOI DEADLINE CLOSED; SUBMISSIONS UNDER REVIEW
- Track 4 – Veterans/Military: clinical repurposing trials to address unmet medical needs of US veterans and/or active US military, including but not limited to mental health, post-traumatic stress disorder (PTSD) and brain injuries.
- Clinical Repurposing Research to Impact Veterans/Military 2024: accepting budgets of up to $75,000 to a U.S.-based institution for a repurposing clinical trial in any disease area impacting veterans or active military, such as mental health, PTSD and brain injuries. LOI DEADLINE CLOSED; SUBMISSIONS UNDER REVIEW
More information on our Funding Opportunities / RFPs page.
Previous RFPs:
Clinical Repurposing Research to Impact Veterans/Military 2023: INVITE ONLY. Up to $75,000 to a U.S.-based institution for a repurposing clinical trial in any disease area impacting veterans or active military, including mental health, PTSD and brain injuries. CLOSED; FUNDING DECISIONS MADE.
Clinical Repurposing Research to Impact Veterans 2021: up to $50,000 to a U.S.-based institution for a repurposing clinical trial in any disease area impacting veterans, including mental health, PTSD and brain injuries. FOUR CLINICAL TRIALS SELECTED FOR FUNDING.
As we develop and grow this Veterans / Military Community, we thank our early funding partner:
Additional thanks to:
The Arthur Thomas Alm Trust
Our ongoing veterans trials:
Current Veteran / Military Trials
Veteran / Military: Completed Trials and Press Releases
(in the past 5 years)
Events
Diversity of Clinical Trial Researchers and Patients: A Repurposing Opportunity?
November 2021
Virtual
A dialogue on the dual opportunities of clinical trial diversity to impact health disparities and/or improve minority leadership in scientific research.
Real World Data Through a Patient’s Lens
October 2021
Virtual
A conversation on Real World Data (RWD) and case reports from clinicians and researchers.
How Patients Impact the 505(b)(2) Regulatory Process
October 2020
Virtual
A patient-focused conversation on the 505(b)(2) regulatory process and how patients, caregivers and patient advocacy groups can engage with both industry and regulators to support the drug development process, share their real-world perspectives for clinical trial planning and represent the patient view throughout the drug approval process.
CureAccelerator Live! for Chicago 2020
September 2020
Virtual
Four finalists from Chicago-based institutions competing for up to $50,000 to fund their groundbreaking repurposing clinical trials, including one from the VA for brain injury. Watch Dr. Lindsey pitch his brain injury project.
CureAccelerator Live! for the Mid-Atlantic 2018
October 2018
Washington, DC
Four finalists from Mid-Atlantic institutions competing for up to $50,000 to fund their groundbreaking repurposing clinical trials, including one for traumatic nerve injury. Watch the 3-minute event highlights video.